Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

The Hsp90 machinery facilitates the transport of diphtheria toxin into human cells.

Schuster M, Schnell L, Feigl P, Birkhofer C, Mohr K, Roeder M, Carle S, Langer S, Tippel F, Buchner J, Fischer G, Hausch F, Frick M, Schwan C, Aktories K, Schiene-Fischer C, Barth H.

Sci Rep. 2017 Apr 4;7(1):613. doi: 10.1038/s41598-017-00780-x.

2.

Thioredoxin reductase inhibitor auranofin prevents membrane transport of diphtheria toxin into the cytosol and protects human cells from intoxication.

Schnell L, Dmochewitz-Kück L, Feigl P, Montecucco C, Barth H.

Toxicon. 2016 Jun 15;116:23-8. doi: 10.1016/j.toxicon.2015.04.012. Epub 2015 Apr 24.

PMID:
25911959
3.

A profile of Norman Breslow.

Feigl P.

Lifetime Data Anal. 2007 Dec;13(4):439-41. Epub 2007 Sep 2. No abstract available.

PMID:
17768680
4.

Ascorbyl palmitate and its synergism to tocopherols.

Wagner KH, Feigl P, Elmadfa I.

Forum Nutr. 2003;56:347-8. Review. No abstract available.

PMID:
15806929
5.

An educational program to increase cervical and breast cancer screening in Hispanic women: a Southwest Oncology Group study.

Hansen LK, Feigl P, Modiano MR, Lopez JA, Escobedo Sluder S, Moinpour CM, Pauler DK, Meyskens FL.

Cancer Nurs. 2005 Jan-Feb;28(1):47-53.

6.

Prostate Cancer Prevention Trial (PCPT) update.

Coltman CA Jr, Thompson IM Jr, Feigl P.

Eur Urol. 1999;35(5-6):544-7.

PMID:
10325520
7.

Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study.

Ahnen DJ, Feigl P, Quan G, Fenoglio-Preiser C, Lovato LC, Bunn PA Jr, Stemmerman G, Wells JD, Macdonald JS, Meyskens FL Jr.

Cancer Res. 1998 Mar 15;58(6):1149-58.

8.

Improving breast self-examination compliance: a Southwest Oncology Group randomized trial of three interventions.

Strickland CJ, Feigl P, Upchurch C, King DK, Pierce HI, Grevstad PK, Bearden JD 3rd, Dawson M, Loewen WC, Meyskens FL Jr.

Prev Med. 1997 May-Jun;26(3):320-32.

9.

Southwest Oncology Group (SWOG).

Loll LC, Moinpour CM, Feigl P.

J Natl Cancer Inst Monogr. 1996;(20):83-5. No abstract available.

PMID:
8750474
10.

Design of the Prostate Cancer Prevention Trial (PCPT).

Feigl P, Blumenstein B, Thompson I, Crowley J, Wolf M, Kramer BS, Coltman CA Jr, Brawley OW, Ford LG.

Control Clin Trials. 1995 Jun;16(3):150-63.

PMID:
7540965
11.

Chemoprevention of cervical cancer with folic acid: a phase III Southwest Oncology Group Intergroup study.

Childers JM, Chu J, Voigt LF, Feigl P, Tamimi HK, Franklin EW, Alberts DS, Meyskens FL Jr.

Cancer Epidemiol Biomarkers Prev. 1995 Mar;4(2):155-9.

12.

Chemoprevention of prostate cancer with finasteride.

Thompson I, Feigl P, Coltman C.

Important Adv Oncol. 1995:57-76. Review. No abstract available.

PMID:
7672814
13.

Ethnic variation in the incidence, diagnosis, prognosis, and follow-up of children with Wilms' tumor.

Breslow N, Olshan A, Beckwith JB, Moksness J, Feigl P, Green D.

J Natl Cancer Inst. 1994 Jan 5;86(1):49-51. No abstract available.

PMID:
8271283
14.

Pitfalls in quality-of-life assessment: lessons from a Southwest Oncology Group breast cancer clinical trial.

Hayden KA, Moinpour CM, Metch B, Feigl P, O'Bryan RM, Green S, Osborne CK.

Oncol Nurs Forum. 1993 Oct;20(9):1415-9.

PMID:
8265446
15.

The degree of roentgenographic parenchymal opacities attributable to smoking among asbestos-exposed subjects.

Barnhart S, Thornquist M, Omenn GS, Goodman G, Feigl P, Rosenstock L.

Am Rev Respir Dis. 1990 May;141(5 Pt 1):1102-6.

PMID:
2339831
16.

Quality of life assessment in Southwest Oncology Group trials.

Moinpour CM, Hayden KA, Thompson IM, Feigl P, Metch B.

Oncology (Williston Park). 1990 May;4(5):79-84, 89; discussion 104. Review.

PMID:
2143413
17.

Early detection and control of cancer in clinical practice.

Bergner M, Allison CJ, Diehr P, Ford LG, Feigl P.

Arch Intern Med. 1990 Feb;150(2):431-6.

PMID:
2302018
18.

Treatment modality and quality differences for black and white breast-cancer patients treated in community hospitals.

Diehr P, Yergan J, Chu J, Feigl P, Glaefke G, Moe R, Bergner M, Rodenbaugh J.

Med Care. 1989 Oct;27(10):942-58.

PMID:
2796413
19.

Quality of life end points in cancer clinical trials: review and recommendations.

Moinpour CM, Feigl P, Metch B, Hayden KA, Meyskens FL Jr, Crowley J.

J Natl Cancer Inst. 1989 Apr 5;81(7):485-95. Review.

20.

Embryonal carcinoma of the testis.

Vugrin D, Chen A, Feigl P, Laszlo J.

Cancer. 1988 Jun 1;61(11):2348-52.

PMID:
3365662
21.

Studying patterns of cancer care: how useful is the medical record?

Feigl P, Glaefke G, Ford L, Diehr P, Chu J.

Am J Public Health. 1988 May;78(5):526-33.

22.

The role of intervention studies in ascertaining the contribution of dietary factors in lung cancer. The Seattle chemoprevention trial of retinoids in asbestos-exposed workers.

Omenn GS, Goodman GE, Kleinman GD, Rosenstock L, Barnhart S, Feigl P, Thomas DB, Kalman D, Lund B, Prentice RL, et al.

Ann N Y Acad Sci. 1988;534:575-83. No abstract available.

PMID:
3389681
23.

Age trends of lung cancer stage at diagnosis. Implications for lung cancer screening in the elderly.

O'Rourke MA, Feussner JR, Feigl P, Laszlo J.

JAMA. 1987 Aug 21;258(7):921-6.

PMID:
3613022
24.

The effect of age on the care of women with breast cancer in community hospitals.

Chu J, Diehr P, Feigl P, Glaefke G, Begg C, Glicksman A, Ford L.

J Gerontol. 1987 Mar;42(2):185-90.

PMID:
3819344
25.

Rationale and design of cancer chemoprevention studies in Seattle.

Prentice RL, Omenn GS, Goodman GE, Chu J, Henderson MM, Feigl P, Kleinman GD, Thomas DB, Hutchinson ML, Lund B, et al.

Natl Cancer Inst Monogr. 1985 Dec;69:249-58.

PMID:
3914621
26.

Accuracy of basic cancer patient data: results from an extensive recoding survey.

Polissar L, Feigl P, Lane WW, Glaefke G, Dahlberg S.

J Natl Cancer Inst. 1984 May;72(5):1007-14.

PMID:
6585578
27.

A novel method of assessing completeness of tumor registration.

Heiberger RM, Miller CL, Feigl P, Lane WW, Glaefke G.

Cancer. 1983 Jun 15;51(12):2362-6.

PMID:
6850515
28.

Reliability of basic cancer patient data.

Feigl P, Polissar L, Lane WW, Guinee V.

Stat Med. 1982 Jul-Sep;1(3):191-204.

PMID:
7187093
29.

Improved three-year disease-free survival in osteogenic sarcoma.

Bleyer WA, Haas JE, Feigl P, Greenlee TK, Schaller RT Jr, Morgan A, Pendergrass TW, Johnson FL, Bernstein ID, Chard RL Jr, Hartmann JR.

J Bone Joint Surg Br. 1982;64(2):233-8.

PMID:
6978340
30.

A profile of treatment approaches used at comprehensive cancer centers.

Laszlo J, Lenhard R, Dahlberg S, Feigl P.

J Chronic Dis. 1982;35(11):853-9.

PMID:
6292252
31.

U.S. centralized cancer patient data system for uniform communication among cancer centers.

Feigl P, Breslow NE, Laszlo J, Priore RL, Taylor WF.

J Natl Cancer Inst. 1981 Nov;67(5):1017-24.

PMID:
6946244
32.

Utilization of the Centralized Cancer Patient Data System.

Laszlo J, Feigl P.

Prog Clin Biol Res. 1981;57:31-49. No abstract available.

PMID:
7330040
33.

Training of statisticians for clinical trials.

Feigl P.

Biometrics. 1980 Dec;36(4):677-8. No abstract available.

PMID:
7248435
34.

Evaluation of clorazepate (Tranxene) as an anticonvulsant--a pilot study.

Troupin AS, Friel P, Wilensky AJ, Morretti-Ojemann L, Levy RH, Feigl P.

Neurology. 1979 Apr;29(4):458-66.

PMID:
35767
35.
36.

Carbamazepine--a double-blind comparison with phenytoin.

Troupin A, Ojemann LM, Halpern L, Dodrill C, Wilkus R, Friel P, Feigl P.

Neurology. 1977 Jun;27(6):511-9.

PMID:
405624
37.

Reproducibility of control strains for antibiotic susceptibility testing.

Coyle MB, Lampe MF, Aitken CL, Feigl P, Sherris JC.

Antimicrob Agents Chemother. 1976 Sep;10(3):436-40.

38.

The treatment of Wilms' tumor: Results of the national Wilms' tumor study.

D'Angio GJ, Evans AE, Breslow N, Beckwith B, Bishop H, Feigl P, Goodwin W, Leape LL, Sinks LF, Sutow W, Tefft M, Wolff J.

Cancer. 1976 Aug;38(2):633-46.

PMID:
184912
39.

Histocompatibility antigens in childhood-onset arthritis.

Schaller JG, Ochs HD, Thomas ED, Nisperos B, Feigl P, Wedgwood RJ.

J Pediatr. 1976 Jun;88(6):926-30.

PMID:
1271190
40.

Partial antibiotic therapy in Haemophilus infuenzae meningitis. Its effect on cerebrospinal fluid abnormalities.

Davis SD, Hill HR, Feigl P, Arnstein EJ.

Am J Dis Child. 1975 Jul;129(7):802-7.

PMID:
1080009
41.

Radiographic study of mycoplasma pneumoniae pneumonia.

Foy HM, Loop J, Clarke ER, Mansy AW, Spence WF, Feigl P, Grayston JT.

Am Rev Respir Dis. 1973 Sep;108(3):469-74. No abstract available.

PMID:
4745244
42.

Comparison of treatments with several antibiotics in experimental infections due to methicillin-resistant Staphylococcus aureus.

Bulger RJ, Feigl P, Nielson K.

J Infect Dis. 1972 Dec;126(6):674-8. No abstract available.

PMID:
4489479
43.

A comparison of the ultrastructure of the small-colony variant and the parent strain of methicillin-resistant Staphylococcus aureus.

Bulger RJ, Collman M, Feigl P, Bulger RE.

J Infect Dis. 1972 Jan;125(1):1-4. No abstract available.

PMID:
4480947
44.

Evaluation of Doppler ultrasound examination. Its use in diagnosis of lower extremity venous disease.

Sigel B, Popky GL, Mapp EM, Feigl P, Felix WR Jr, Ipsen J.

Arch Surg. 1970 May;100(5):535-40. No abstract available.

PMID:
5438566
45.

A biomathematical model for prevalence of Trichomonas vaginalis.

Ipsen J, Feigl P.

Am J Epidemiol. 1970 Feb;91(2):175-84. No abstract available.

PMID:
5416251
46.

Serum urate concentrations in the Australian aboriginal.

Emmerson BT, Douglas W, Doherty RL, Feigl P.

Ann Rheum Dis. 1969 Mar;28(2):150-6. No abstract available.

47.

Comparison of clinical and Doppler ultrasound evaluation of confirmed lower extremity venous disease.

Sigel B, Popky GL, Wagner DK, Boland JP, Mapp EM, Feigl P.

Surgery. 1968 Jul;64(1):332-8. No abstract available.

PMID:
5658736
48.

Independence of hyperplastic and hypertrhic responses in liver regeneration.

Sigel B, Baldia LB, Menduke H, Feigl P.

Surg Gynecol Obstet. 1967 Jul;125(1):95-100. No abstract available.

PMID:
5338312
49.

Appropriate scores for clinical and public health variables.

Ipsen J, Feigl P.

Am J Public Health Nations Health. 1966 Aug;56(8):1287-95. No abstract available.

50.

Estimation of exponential survival probabilities with concomitant information.

Feigl P, Zelen M.

Biometrics. 1965 Dec;21(4):826-38. No abstract available.

PMID:
5857231

Supplemental Content

Support Center